|
Russian Patent for Cyclosporin Neuroprotection Granted to Maas BiolAB BIOWIRE2K This Russian patent joins Maas patents in North America (USA, Canada, Mexico), Europe (Austria, Belgium, Czech Republic, Denmark, France, Germany, Greece, Ireland, Italy, Latvia, Lithuania, Luxembourg, Monaco, Netherlands, Portugal, Slovenia, Spain, Sweden, Switzerland, United Kingdom), Africa (Ghana, Kenya, Lesotho, Malawi, Sudan, Swaziland, Uganda, Zimbabwe) and the Antipodes (Australia, New Zealand). Maas BiolAB is a privately held neuropharmaceutical corporation based in Albuquerque, NM, USA developing cyclosporin drugs for the neurodegenerative diseases of Alzheimer's, Parkinson's, Huntington's and amyotrophic lateral sclerosis. NeuroPharma AB is a Maas corporate and research partner developing NeuroSTAT(TM), a proprietary, non-toxic intravenous cyclosporin formula for traumatic brain injury, spinal cord injury and stroke. NeuroPharma AB is located in the Medicon Valley biotechnology center of Sweden, with close ties to the Wallenberg Neuroscience Center, Lund University. Maas BiolAB, LLC NeuroPharma AB |